The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Contributions of β-Cell Dysfunction and Insulin Resistance to the Pathogenesis of Impaired Glucose Tolerance and Impaired Fasting Glucose
Open accessAbstract
Impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) are intermediate states in glucose metabolism that exist between normal glucose tolerance and overt diabetes. Epidemiological studies demonstrate that the two categories describe distinct populations with only partial overlap, suggesting that different metabolic abnormalities characterize IGT and IFG. Insulin resistance and impaired β-cell function, the primary defects observed in type 2 diabetes, both can be detected in subjects with IGT and IFG. However, clinical studies suggest that the site of insulin resistance varies between the two disorders. While subjects with IGT have marked muscle insulin resistance with only mild hepatic insulin resistance, subjects with IFG have severe hepatic insulin resistance with normal or near-normal muscle insulin sensitivity. Both IFG and IGT are characterized by a reduction in early-phase insulin secretion, while subjects with IGT also have impaired late-phase insulin secretion. The distinct metabolic features present in subjects with IFG and IGT may require different therapeutic interventions to prevent their progression to type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, progressive β-cell failure is required and ultimately responsible for type 2 diabetes to become fully manifest ( 1 , 34 , 35 , 37 , 38 ).”
From Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes (2009) · cites this paper as [37]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Because the great majority of glucose disposal after intravenous glucose administration occurs in muscle, these results provide strong evidence that insulin resistance in muscle is the earliest demonstrable defect in the natural history of type 2 diabetes, but that the development of overt type 2 diabetes occurs only in those individuals whose β-cells are unable to compensate for the defect in”
From Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes (2009) · cites this paper as [37]
Experimental — accuracy not yet measuredIn the citing paper
“Fasting glucose is maintained between 3.9 and 5.6 mmol/L37 and the post-meal increases rarely exceed 3 mmol/L.38”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [37]
In the citing paper
“This is in line with the notion that insulin resistance starts years before diabetes development and that decreased beta-cell function is already present in the prediabetic stage.37,42”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [37]
In the citing paper
“Studies using different measures of β-cell function have reported severely abnormal (up to 80% decreased) insulin secretion in prediabetic people.37,42,48”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [37]
In the citing paper
“Both IFG and IGT subjects present with insulin resistance, however the site of insulin resistance is different: High hepatic insulin resistance is a typical finding in IFG with almost normal values in skeletal muscle.38,39,45 In IGT, the main site of insulin resistance is the muscle with only modest changes in liver insulin sensitivity.37,38”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Self-citationReport of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
Self-citationClassification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Bonora, E., Targher, G., Alberiche, M., Bonadonna, R. C., Saggiani, F., Zenere, M. B., Monauni, T., & Muggeo, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.57 · Cited by 2,456
Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940
Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405
Buchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339
(1999) · The Lancet · doi:10.1016/s0140-6736(98)12131-1 · Cited by 1,313
DeFronzo, R. A., Gunnarsson, R., Björkman, O., Olsson, M., & Wahren, J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111938 · Cited by 1,167
Self-citationUnwin, N. C., Shaw, J. E., Zimmet, P., & Alberti, K. G. M. M. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00835.x · Cited by 1,112
The Rising Prevalence of Diabetes and Impaired Glucose Tolerance
Dunstan, D. W., Zimmet, P., Welborn, T. A., de Courten, M., Cameron, A. J., Sicree, R. A., Dwyer, T., Colagiuri, S., Jolley, D., Knuiman, M. W., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.5.829 · Cited by 906
Bergman, R. N., Prager, R., Volund, A., & Olefsky, J. M. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112886 · Cited by 772
Creutzfeldt, W. (1979) · Diabetologia · doi:10.1007/bf01225454 · Cited by 731
Phillips, D. I. W., Clark, P. M., Hales, C. N., & Osmond, C. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00273.x · Cited by 631
Gerich, J. E., Meyer, C., Woerle, H. J., & Stümvoll, M. (2001) · Diabetes Care · doi:10.2337/diacare.24.2.382 · Cited by 602
Gabir, M. M., Hanson, R. L., Dabelea, D., Imperatore, G., Roumain, J., Bennett, P. H., & Knowler, W. C. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1108 · Cited by 568
Ferrannini, E., Gastaldelli, A., Miyazaki, Y., Matsuda, M., Mari, A., & DeFronzo, R. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1133 · Cited by 540
Self-citationT., V., T., K., S., M., & J., H. (2002) · Diabetologia · doi:10.1007/s00125-002-0878-6 · Cited by 518
Accurate Assessment of β-Cell Function
Bergman, R. N., Ader, M., Hücking, K., & Citters, G. V. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s212 · Cited by 517
DeFronzo, R. A., Ferrannini, E., & Simonson, D. C. (1989) · Metabolism · doi:10.1016/0026-0495(89)90129-7 · Cited by 515
Self-citationBanting Lecture 1997. Control of glucose uptake and release by the liver in vivo.
Cherrington, A. D. (1999) · Diabetes · doi:10.2337/diabetes.48.5.1198 · Cited by 500
Abdul-Ghani, M. A., Jenkinson, C. P., Richardson, D. K., Tripathy, D., & DeFronzo, R. A. (2006) · Diabetes · doi:10.2337/db05-1200 · Cited by 500
Self-citationThe Effect of Insulin Treatment on Insulin Secretion and Insulin Action in Type II Diabetes Mellitus
Garvey, W. T., Olefsky, J. M., Griffin, J., Hamman, R. F., & Kolterman, O. G. (1985) · Diabetes · doi:10.2337/diab.34.3.222 · Cited by 488
The Diabetes Prevention Program Research Group (2005) · Diabetes · doi:10.2337/diabetes.54.8.2404 · Cited by 446
The Disposal of an Oral Glucose Load in Healthy Subjects: A Quantitative Study
Ferrannini, E., Bjorkman, O., Reichard, G. A., Pilo, A., Olsson, M., Wahren, J., & DeFronzo, R. A. (1985) · Diabetes · doi:10.2337/diab.34.6.580 · Cited by 439
Self-citationThe role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus
Pratley, R. E., & Weyer, C. (2001) · Diabetologia · doi:10.1007/s001250100580 · Cited by 421
Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study
Perseghin, G., Ghosh, S., Gerow, K., & Shulman, G. I. (1997) · Diabetes · doi:10.2337/diab.46.6.1001 · Cited by 367
Tripathy, D., Carlsson, M., Almgren, P., Isomaa, B., Taskinen, M., Tuomi, T., & Groop, L. (2000) · Diabetes · doi:10.2337/diabetes.49.6.975 · Cited by 358
Self-citationDECODE Study Group, on behalf of the European Diabetes Epidemiology Study Group, Tuomilehto, J., Jousilahti, P., & Lindström, J. (1998) · BMJ · doi:10.1136/bmj.317.7155.371 · Cited by 349
Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study
Gastaldelli, A., Ferrannini, E., Miyazaki, Y., Matsuda, M., & DeFronzo, R. A. (2004) · Diabetologia · doi:10.1007/s00125-003-1263-9 · Cited by 338
Self-citationEffect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats.
Rossetti, L., Shulman, G. I., Zawalich, W. S., & DeFronzo, R. A. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113157 · Cited by 330
Self-citationShaw, J. E., Zimmet, P., de Courten, M., Dowse, G. K., Chitson, P., Gareeboo, H., Hemraj, F., Fareed, D., Tuomilehto, J. O., & Alberti, K. G. M. M. (1999) · Diabetes Care · doi:10.2337/diacare.22.3.399 · Cited by 329
Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., Palmer, J. P., et al. (1993) · Diabetes · doi:10.2337/diabetes.42.11.1663 · Cited by 328
The evolution of β‐cell dysfunction and insulin resistance in type 2 diabetes
Bergman, R. N., Finegood, D. T., & Kahn, S. E. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.32.s3.5.x · Cited by 302
DeFronzo, R. A., Ferrannini, E., Hendler, R., Wahren, J., & Felig, P. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.10.5173 · Cited by 296
Self-citationWeyer, C., Bogardus, C., & Pratley, R. E. (1999) · Diabetes · doi:10.2337/diabetes.48.11.2197 · Cited by 292
Splanchnic and Peripheral Disposal of Oral Glucose in Man
Katz, L. D., Glickman, M. G., Rapoport, S. I., Ferrannini, E., & DeFronzo, R. A. (1983) · Diabetes · doi:10.2337/diab.32.7.675 · Cited by 287
Self-citationGulli, G., Ferrannini, E., Stern, M., Haffner, S., & DeFronzo, R. A. (1992) · Diabetes · doi:10.2337/diab.41.12.1575 · Cited by 283
Self-citationIn Vivo Insulin Action Is Familial Characteristic in Nondiabetic Pima Indians
Lillioja, S., Mott, D. M., Zawadzki, J. K., Young, A. A., Abbott, W. G. H., Knowler, W. C., Bennett, P. H., Moll, P. P., & Bogardus, C. (1987) · Diabetes · doi:10.2337/diab.36.11.1329 · Cited by 268
Harris, M. I., Eastman, R. C., Cowie, C. C., Flegal, K. M., & Eberhardt, M. S. (1997) · Diabetes Care · doi:10.2337/diacare.20.12.1859 · Cited by 262
Prato, S. D., & Tiengo, A. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.198 · Cited by 241
Markolf Hanefeld, E., Koehler, C., Fuecker, K., Henkel, E., Schäper, F., & Temelkova-Kurktschiev, T. S. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.868 · Cited by 238
Meier, J. J., Hücking, K., Holst, J. J., Deacon, C. F., Schmiegel, W., & Nauck, M. A. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2497 · Cited by 233
Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach
Bergman, R. N. (1989) · Diabetes · doi:10.2337/diabetes.38.12.1512 · Cited by 215
Olson, L. K., Redmon, J. B., Towle, H. C., & Robertson, R. P. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116596 · Cited by 212
Tripathy, D., Almgren, P., Tuomi, T., & Groop, L. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2204 · Cited by 206
Self-citationComparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts
Qiao, Q., Nakagami, T., Tuomilehto, J., Borch‐Johnsen, K., Balkau, B., Iwamoto, Y., & Tajima, N. (2000) · Diabetologia · doi:10.1007/s001250051557 · Cited by 206
Ellenberg and Rifkinʼs Diabetes Mellitus
Rifkin, H., Porte, D., & Gallon, D. J. (1992) · The Endocrinologist · doi:10.1097/00019616-199203000-00012 · Cited by 195
GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice
Hansotia, T., & Drucker, D. J. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.07.019 · Cited by 187
The Significance of Impaired Fasting Glucose Versus Impaired Glucose Tolerance
Schianca, G. P. C., Rossi, A., Sainaghi, P. P., Maduli, E., & Bartoli, E. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1333 · Cited by 180
Festa, A., D’Agostino, R., Hanley, A. J. G., Karter, A. J., Saad, M. F., & Haffner, S. M. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1549 · Cited by 180
Leahy, J. L., Bonner‐Weir, S., & Weir, G. C. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113470 · Cited by 172
Regulation of hepatic glucose metabolism in humans
DeFronzo, R. A., & Ferrannini, E. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030204 · Cited by 167
Self-citationVauhkonen, I., NISKANEN, L. K., Vanninen, E. J., Kainulainen, S., Uusitupa, M. I. J., & Laakso, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci716 · Cited by 157
de Vegt, F., Dekker, J. M., Stehouwer, C. D. A., Nijpels, G., Bouter, L. M., & Heine, R. J. (1998) · Diabetes Care · doi:10.2337/diacare.21.10.1686 · Cited by 153
Arslanian, S. A., Bacha, F., Saad, R., & Gungor, N. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.115 · Cited by 138
Lillioja, S., Nyomba, B. L. G., Saad, M. F., Ferraro, R. T., CASTILLO, C., Bennett, P. H., & Bogardus, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-4-866 · Cited by 136
Low Acute Insulin Secretory Responses in Adult Offspring of People With Early Onset Type 2 Diabetes
Gautier, J., Wilson, C., Weyer, C., Mott, D., Knowler, W. C., Cavaghan, M. K., Polonsky, K. S., Bogardus, C., & Pratley, R. E. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1828 · Cited by 135
Impaired glucose tolerance and fasting hyperglycaemia have different characteristics
Davies, M. J., Raymond, N. T., Day, J., Hales, C. N., & Burden, A. C. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00246.x · Cited by 132
Loss of beta cell function as fasting glucose increases in the non-diabetic range
Godsland, I. F., Jeffs, J. A. R., & Johnston, D. G. (2004) · Diabetologia · doi:10.1007/s00125-004-1454-z · Cited by 131
Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance
Haffner, S. M., Miettinen, H., GASKILL, S. P., & Stern, M. P. (1996) · Diabetologia · doi:10.1007/bf02658507 · Cited by 127
Ferrannini, E., Gastaldelli, A., Miyazaki, Y., Matsuda, M., Pettiti, M., Natali, A., Mari, A., & DeFronzo, R. A. (2003) · Diabetologia · doi:10.1007/s00125-003-1169-6 · Cited by 123
Self-citationNovoa, F. J., Boronat, M., Saavedra, P., Díaz-Cremades, J., Varillas, V. F., Roche, F. L., Alberiche, M., & Carrillo, A. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2388 · Cited by 118
In vivo insulin action is familial characteristic in nondiabetic Pima Indians
Lillioja, S., Mott, D. M., Zawadzki, J. K., et al. (1987) · Diabetes · doi:10.2337/diabetes.36.11.1329 · Cited by 107
The disposal of an oral glucose load in healthy subjects. A quantitative study
Ferrannini, E., Bjorkman, O., Reichard, G. A., et al. (1985) · Diabetes · doi:10.2337/diabetes.34.6.580 · Cited by 106
Kashyap, S. R., Belfort, R., Berria, R., Suraamornkul, S., Pratipranawatr, T., Finlayson, J., Barrentine, A., Bajaj, M., Mandarino, L., DeFronzo, R., et al. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00541.2003 · Cited by 103
Self-citationRask, E., Olsson, T., Söderberg, S., Holst, J. J., Tura, A., Pacini, G., & Åhrén, B. (2004) · Metabolism · doi:10.1016/j.metabol.2003.11.011 · Cited by 99
Gulli, G., Ferrannini, E., Stern, M. P., et al. (1992) · Diabetes · doi:10.2337/diabetes.41.12.1575 · Cited by 93
Lowering the Criterion for Impaired Fasting Glucose Will Not Provide Clinical Benefit
Davidson, M. B., Landsman, P. B., & Alexander, C. M. (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3329 · Cited by 83
Osei, K., Gaillard, T. R., & Schuster, D. P. (1997) · Diabetes Care · doi:10.2337/diacare.20.3.396 · Cited by 74
Disturbances in β-Cell Function in Impaired Fasting Glycemia
van Haeften, T. W., Pimenta, W., Mitrakou, A., Korytkowski, M., Jenssen, T., Yki-Jarvinen, H., & Gerich, J. E. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s265 · Cited by 70
Splanchnic and peripheral disposal of oral glucose in man
Katz, L. D., Glickman, M. G., Rapoport, S., et al. (1983) · Diabetes · doi:10.2337/diabetes.32.7.675 · Cited by 70
Lowering the Cut Point for Impaired Fasting Glucose
Schriger, D. L., & Lorber, B. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.592 · Cited by 66
Åhrén, B., & Pacini, G. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.4.e701 · Cited by 66
Comparison of ADA and WHO criteria for diagnosis of diabetes and glucose intolerance
Available, N. A. N. (1998) · Diabetologia · doi:10.1007/s001250051040 · Cited by 64
Ko, G. T. C., Chan, J. C. N., Woo, J., & Cockram, C. S. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2094 · Cited by 60
Who are more insulin resistant, people with IFG or people with IGT?
Wasada, T., Kuroki, H., Katsumori, K., Arii, H., Sato, A., Aoki, K., Jimba, S., & Hanai, G. (2004) · Diabetologia · doi:10.1007/s00125-004-1339-1 · Cited by 55
Diamond, M. P., Thornton, K. L., Connolly-Diamond, M., Sherwin, R. S., & DeFronzo, R. A. (1995) · Journal of the Society for Gynecologic Investigation · doi:10.1016/1071-5576(95)00023-8 · Cited by 54
Self-citationKorytkowski, M. T., Berga, S. L., & Horwitz, M. J. (1995) · Metabolism · doi:10.1016/0026-0495(95)90003-9 · Cited by 52
Botas, P., Delgado, E., Castaño, G., de Greñu, C. D., Prieto, J., & Díaz-Cadórniga, F. J. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01006.x · Cited by 49
Abdul-Ghani, M. A., Sabbah, M., Kher, J., Minuchin, O., Vardi, P., & Raz, I. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.595 · Cited by 47
Self-citationPrediabetes: prediction and prevention trials
Vendrame, F., & Gottlieb, P. A. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2003.12.006 · Cited by 45
Comparison of ADA and WHO criteria for the diagnosis of diabetes in elderly Koreans
Choi, K., Lee, J., Kim, D.-R., Kim, S., Shin, D., Kim, N., Park, I. B., Choi, D., & Baik, S. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00783.x · Cited by 44
Ehrmann, D. A., Breda, E., Cavaghan, M. K., Bajramovic, S., Imperial, J., TOFFOLO, G. M., Cobelli, C., & Polonsky, K. S. (2002) · Diabetologia · doi:10.1007/s00125-002-0776-y · Cited by 41
Byrne, M. M., Gliem, K., Wank, U., Arnold, R., Katschinski, M., Polonsky, K. S., & Göke, B. (1998) · Diabetes · doi:10.2337/diabetes.47.8.1259 · Cited by 32
Snehalatha, C., Ramachandran, A., Sivasankari, S., Satyavani, K., & Viswanathan, V. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.388 · Cited by 29
Comparing the ADA 1997 and the WHO 1999 criteria: Prevalence of Diabetes in India Study
SADIKOT, S. M., Nigam, A., Das, S., Bajaj, S., Zargar, A. H., Prasannakumar, K. M., Sosale, A., Munichoodappa, C., Seshiah, V., Singh, S. K., et al. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.04.009 · Cited by 27
Acute hyperglycemia alters the ability of the normal β-cell to sense and respond to glucose
Meyer, J., Sturis, J., Katschinski, M., Arnold, R., Göke, B., & Byrne, M. M. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00427.2001 · Cited by 25
Piché, M., Després, J., Pascot, A., Nadeau, A., Tremblay, A., Weisnagel, S. J., Bergeron, J., & Lemieux, S. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01234.x · Cited by 14
Metabolic characteristics in individuals with impaired glucose homeostasis
Hsieh, C.-H., Kuo, S.-W., Hung, Y.-J., Shen, D.-C., Ho, C.-T., Lian, W.-C., Lee, C., Fan, S. C., & Pei, D. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2005.00494.x · Cited by 10
Sargın, M., IKIISIK, M., Sargın, H., Orçun, A., Müjgan, K. A. Y. A., Gözü, H. I., Dabak, R., Bayramıçlı, O. U., & YAYLA, A. (2005) · Endocrine Journal · doi:10.1507/endocrj.52.531 · Cited by 7
Flagged first, then by citations
Research works printed but not linked: 1
- Qiau Q, Hu G, Tuomilehto J, Balkau B, Bord-Johnsen K, for the DECODE Study Group: Age and sex specific prevalence of diabetes and impaired glucose regulation in 13 European cohorts. In Proceedings of the 37th Annual Meeting of the European Diabetes Epidemiology Group, 2002. Oxford, U.K., European Diabetes Epidemiology Group, 2002, p. A37
Cited by
Sorted by citations
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Self-citationPrediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958
DeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., Hu, F. B., Kahn, C. R., Raz, I., Shulman, G. I., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.19 · Cited by 2,611
Self-citationSkeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
DeFronzo, R. A., & Tripathy, D. (2009) · Diabetes Care · doi:10.2337/dc09-s302 · Cited by 2,102
Self-citationImpaired Fasting Glucose and Impaired Glucose Tolerance
Nathan, D. M., Davidson, M. B., DeFronzo, R. A., Heine, R. J., Henry, R. R., Pratley, R., & Zinman, B. (2007) · Diabetes Care · doi:10.2337/dc07-9920 · Cited by 1,396
Self-citation
Metadata
- Authors
- Abdul-Ghani, M. A., Tripathy, D., & DeFronzo, R. A.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2006-05-01
- Volume
- 29
- Issue
- 5
- Pages
- 1130-1139
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4241031718
- Cited by
- 744
- References
- 93
- Citations by year
- 2026: 30 · 2025: 30 · 2024: 61 · 2023: 54 · 2022: 45 · 2021: 33 · 2020: 39 · 2019: 37 · 2018: 32 · 2017: 44 · 2016: 45 · 2015: 37 · 2014: 35 · 2013: 38 · 2012: 29
- FWCI
- 29.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- impaired glucose tolerance, impaired fasting glucose, beta-cell dysfunction, insulin resistance, type 2 diabetes, hepatic insulin resistance, skeletal muscle insulin sensitivity, first-phase insulin secretion, prediabetes, diabetes prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
